News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.
chemotherapy for gastric cancer

Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway

While the development of chemoresistance and metastasis are the leading causes of death for gastric cancer patients, the molecular mechanisms involved remain unclear. A new study Bio Med Central study finds that miR-939 acts as a tumor suppressor miRNA in gastric cancer, and miR-939/SLC34A2 axis represents a novel therapeutic strategy for future treatment.

Read Source
X